ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 15 (1) 1-10    DOI: 10.1677/ERC-07-0003
Copyright © 2008 by the Society for Endocrinology.
This Article
Right arrow Free Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Stigliano, A
Right arrow Articles by Toscano, V
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stigliano, A
Right arrow Articles by Toscano, V

Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotane

A Stigliano1,2,, L Cerquetti1,2,, M Borro3, G Gentile3, B Bucci2, S Misiti1,2, P Piergrossi2, E Brunetti2, M Simmaco3 and V Toscano1

1 Endocrinology, II Faculty of Medicine, S Andrea Hospital, ‘Sapienza’ University of Rome, 00189 Rome, Italy2 Research Center, S Pietro Hospital, Rome, Italy3 Diagnostica Molecolare Avanzata, II Faculty of Medicine, S Andrea Hospital, ‘Sapienza’ University of Rome, 00189 Rome, Italy

(Correspondence should be addressed to A Stigliano Endocrinology, II Faculty of Medicine, Research Center, ‘Sapienza’ University of Rome, 00189 Rome, Italy; Email: antonio.stigliano{at}uniroma1.it)

Mitotane, 1,1-dichloro-2-(o-chlorophenyl)-2-(p-chloro-phenyl) ethane (o,p'-DDD), is a compound that represents the effective agent in the treatment of the adrenocortical carcinoma (ACC), able to block cortisol synthesis. In this type of cancer, the biological mechanism induced by this treatment remains still unknown. In this study, we have already shown a greater impairment in the first steps of the steroidogenesis and recognized a little effect on cell cycle. We also evaluated the variation of proteomic profile of the H295R ACC cell line, either in total cell extract or in mitochondria-enriched fraction after treatment with mitotane. In total cell extracts, triose phosphate isomerase, {alpha}-enolase, D-3-phosphoglycerate dehydrogenase, peroxiredoxin II and VI, heat shock protein 27, prohibitin, histidine triad nucleotide-binding protein, and profilin-1 showed a different expression. In the mitochondrial fraction, the following proteins appeared to be down regulated: aldolase A, peroxiredoxin I, heterogenous nuclear ribonucleoprotein A2/B1, tubulin-β isoform II, heat shock cognate 71 kDa protein, and nucleotide diphosphate kinase, whereas adrenodoxin reductase, cathepsin D, and heat shock 70 kDa protein 1A were positively up-regulated. This study represents the first proteomic study on the mitotane effects on ACC. It permits to identify some protein classes affected by the drug involved in energetic metabolism, stress response, cytoskeleton structure, and tumorigenesis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Endocrinology.